Browse Tag

Buy the Dip

Axon Stock Rockets 420% Overseas as Wall Street Targets $1,000 – Should You Buy the Dip?

Axon Stock Rockets 420% Overseas as Wall Street Targets $1,000 – Should You Buy the Dip?

Axon’s Wild Ride: From Plunge to 420% Pop Abroad Axon’s stock has been on a rollercoaster in late October. Last week, shares suddenly plunged ~8.5% in one day, falling from the $700s to about $645 ts2.tech. Notably, this dive occurred despite no major negative news from the company – a stark contrast to the modest uptick in the broader market that day ts2.tech. Market watchers suggest the drop was triggered by technical trading: the sell-off pushed AXON below a key support (its 200-day average), likely triggering stop-loss orders and momentum selling ts2.tech. Indeed, analysts at TheStreet “do not see any
23 October 2025
Progressive (PGR) Stock Tanks After Q3 Miss – Buy-the-Dip or Further Pain?

Progressive (PGR) Stock Tanks After Q3 Miss – Buy-the-Dip or Further Pain?

With these headwinds, short-term outlook is murky. Some market watchers advise caution: TS2.tech reports that “drums of worry are banging louder each day,” urging investors to hedge (e.g. gold or diversified bets) amid fading liquidity and trade risks ts2.tech. Q3 Earnings – In Line on Revenues, Miss on EPS Progressive’s official earnings release shows Q3 net premiums written climbed ~10% year-over-year to $21.38B, and net income of $2.615B (EPS $4.45), up 12% globenewswire.com. On the surface, premium growth and policy count are healthy: agency auto and direct auto policies are each up ~15% from last year. However, EPS lagged estimates
Dalal Street in Turmoil: Sensex Plunges 2,500 Points in a Week – Should You Buy the Dip or Brace for More?

Dalal Street in Turmoil: Sensex Plunges 2,500 Points in a Week – Should You Buy the Dip or Brace for More?

Key Facts: Indian equity benchmarks slumped sharply last week. The BSE Sensex gave up roughly 2,587 points (3.2%) and the Nifty 50 fell about 672 points (2.7%) over six trading days upstox.com livemint.com. This was the worst weekly decline in nearly six months, erasing about 90% of the recent rally from early September upstox.com livemint.com. Markets were roiled by external shocks: U.S. President Trump announced 100% tariffs on imported branded/pharma products and hiked H-1B visa fees to $100,000 per worker. These policy moves hit India’s tech and pharma stocks hard. Sectorally, IT was the biggest laggard (down ~8% on the
27 September 2025
Go toTop